Literature DB >> 25501702

Emerging role of PR domain containing 5 (PRDM5) as a broad tumor suppressor in human cancers.

Xing-sheng Shu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25501702     DOI： 10.1007/s13277-014-2916-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  12 in total

1.  Genomic and proteomic analyses of Prdm5 reveal interactions with insulator binding proteins in embryonic stem cells.

Authors:  Giorgio Giacomo Galli; Matteo Carrara; Chiara Francavilla; Kristian Honnens de Lichtenberg; Jesper Velgaard Olsen; Raffaele Adolfo Calogero; Anders Henrik Lund
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

2.  DNA methylation and carcinogenesis of PRDM5 in cervical cancer.

Authors:  Hai-Yan Cheng; Xiu-Wei Chen; Li Cheng; Yun-Duo Liu; Ge Lou
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

3.  Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma.

Authors:  Shuang-Xiang Tan; Rui-Cheng Hu; Yong-Li Tan; Jing-Jing Liu; Wen-En Liu
Journal:  Tumour Biol       Date:  2014-01-07

Review 4.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

Authors:  Hariharan Easwaran; Hsing-Chen Tsai; Stephen B Baylin
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

5.  Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression.

Authors:  G G Galli; H A Multhaupt; M Carrara; K H de Lichtenberg; I B J Christensen; D Linnemann; E Santoni-Rugiu; R A Calogero; A H Lund
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

Review 6.  Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Authors:  Stephen B Baylin; Joyce E Ohm
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

7.  PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.

Authors:  Yoshiyuki Watanabe; Minoru Toyota; Yutaka Kondo; Hiromu Suzuki; Takashi Imai; Mutsumi Ohe-Toyota; Reo Maruyama; Masanori Nojima; Yasushi Sasaki; Yoshitaka Sekido; Hiroyoshi Hiratsuka; Yasuhisa Shinomura; Kohzoh Imai; Fumio Itoh; Takashi Tokino
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

8.  Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5.

Authors:  Zhijun Duan; Richard E Person; Hu-Hui Lee; Shi Huang; Jean Donadieu; Raffaele Badolato; H Leighton Grimes; Thalia Papayannopoulou; Marshall S Horwitz
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

9.  The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.

Authors:  Xing-sheng Shu; Hua Geng; Lili Li; Jianming Ying; Chunhong Ma; Yajun Wang; Fan Fong Poon; Xian Wang; Ying Ying; Winnie Yeo; Gopesh Srivastava; Sai Wah Tsao; Jun Yu; Joseph J Y Sung; Shi Huang; Anthony T C Chan; Qian Tao
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

10.  The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development.

Authors:  Natalia Meani; Federica Pezzimenti; Gianluca Deflorian; Marina Mione; Myriam Alcalay
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240
View more
  6 in total

1.  Knockdown of lncRNA BDNF-AS suppresses neuronal cell apoptosis via downregulating miR-130b-5p target gene PRDM5 in acute spinal cord injury.

Authors:  Huafeng Zhang; Dongzhe Li; Yi Zhang; Jianqiang Li; Shengli Ma; Jianwei Zhang; Yuanyuan Xiong; Wengang Wang; Ning Li; Lei Xia
Journal:  RNA Biol       Date:  2018-09-10       Impact factor: 4.652

2.  PRDM5 Expression and Essential Role After Acute Spinal Cord Injury in Adult Rat.

Authors:  Jie Liu; Weijie Wu; Jie Hao; Mingchen Yu; Jin Liu; Xinlei Chen; Rong Qian; Feng Zhang
Journal:  Neurochem Res       Date:  2016-11-10       Impact factor: 3.996

3.  Hsa-let-7d-5p Promotes Gastric Cancer Progression by Targeting PRDM5.

Authors:  Xiang Gao; Huiqi Liu; Rong Wang; Mingyu Huang; Qiong Wu; Yang Wang; Wei Zhang; Yongnian Liu
Journal:  J Oncol       Date:  2022-07-07       Impact factor: 4.501

4.  Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway.

Authors:  Pan Zhou; Xing Chen; Mengke Li; Xiaolu Sun; Jiaqi Tan; Xiaomin Wang; Yajing Chu; Yicheng Zhang; Tao Cheng; Jianfeng Zhou; Gaoxiang Wang; Weiping Yuan
Journal:  Cancer Med       Date:  2019-05-23       Impact factor: 4.452

5.  Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice.

Authors:  Wei Xu; Hongchun Li; Liang Wang; Jiamei Zhang; Chunqi Liu; Xuemei Wan; Xiaochong Liu; Yiming Hu; Qiyao Fang; Yuanyuan Xiao; Qian Bu; Hongbo Wang; Jingwei Tian; Yinglan Zhao; Xiaobo Cen
Journal:  Nat Commun       Date:  2020-11-24       Impact factor: 14.919

6.  Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Authors:  Raquel Ordoñez; Marta Kulis; Nuria Russiñol; Vicente Chapaprieta; Arantxa Carrasco-Leon; Beatriz García-Torre; Stella Charalampopoulou; Guillem Clot; Renée Beekman; Cem Meydan; Martí Duran-Ferrer; Núria Verdaguer-Dot; Roser Vilarrasa-Blasi; Paula Soler-Vila; Leire Garate; Estíbaliz Miranda; Edurne San José-Enériz; Juan R Rodriguez-Madoz; Teresa Ezponda; Rebeca Martínez-Turrilas; Amaia Vilas-Zornoza; David Lara-Astiaso; Daphné Dupéré-Richer; Joost H A Martens; Halima El-Omri; Ruba Y Taha; Maria J Calasanz; Bruno Paiva; Jesus San Miguel; Paul Flicek; Ivo Gut; Ari Melnick; Constantine S Mitsiades; Jonathan D Licht; Elias Campo; Hendrik G Stunnenberg; Xabier Agirre; Felipe Prosper; Jose I Martin-Subero
Journal:  Genome Res       Date:  2020-08-20       Impact factor: 9.043
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.